- $1.80bn
- $1.97bn
- $1.11bn
- 75
- 45
- 78
- 72
2019 June 29th | R2020 June 27th | R2021 July 3rd | 2022 July 2nd | 2023 July 1st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 53 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,130 | 1,136 | 1,199 | 1,292 | 1,106 |
Cost of Revenue | |||||
Gross Profit | 651 | 665 | 714 | 774 | 639 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,063 | 1,018 | 1,057 | 1,209 | 1,024 |
Operating Profit | 67.4 | 118 | 142 | 83.2 | 82.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 39.3 | 114 | 131 | 65.1 | 60.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.8 | 49 | 67.5 | 15.5 | 25.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 5.4 | 49 | 67.5 | 15.5 | 25.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.4 | 49 | 67.5 | 15.5 | 25.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.105 | 0.215 | 0.29 | 0.38 | 0.131 |